iShares US Healthcare ETF (IYH)

219.48 -0.16  -0.07% NYSE Arca Feb 21, 20:00 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 219.62
Discount or Premium to NAV -0.06%
Turnover Ratio 6.00%
1 Year Fund Level Flows -437.44M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -0.80% -0.73% 0.67% 83
3M 7.23% 7.33% 9.46% 82
6M 15.13% 15.17% 16.26% 68
YTD 1.74% 1.80% 2.83% 76
1Y 15.53% 15.62% 17.04% 62
3Y 14.04% 14.07% 13.52% 47
5Y 9.23% 9.25% 7.66% 39
10Y 14.74% 14.74% 14.95% 58
15Y 10.73% 10.73% 11.31% 63
20Y -- -- 9.10% --
As of Feb. 21, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.22% 0.22% 0.00%
Stock 99.78% 99.78% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Feb. 20, 2020

Region Exposure

Americas 98.18%
North America 98.18%
Latin America 0.00%
Greater Europe 1.82%
United Kingdom 0.26%
Europe Developed 1.56%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Feb. 20, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.09%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 99.91%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Feb. 20, 2020

Stock Market Capitalization

Giant 49.63%
Large 35.54%
Medium 13.36%
Small 1.46%
Micro 0.00%
As of Feb. 20, 2020

Stock Style Exposure

Large Cap Value 27.73%
Large Cap Blend 39.00%
Large Cap Growth 18.47%
Mid Cap Value 1.86%
Mid Cap Blend 2.11%
Mid Cap Growth 9.39%
Small Cap Value 0.20%
Small Cap Blend 0.36%
Small Cap Growth 0.87%
As of Feb. 20, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
JNJ Johnson & Johnson 9.33% 149.93 +1.05%
UNH UnitedHealth Group Inc 6.84% 301.43 -0.23%
MRK Merck & Co Inc 5.02% 82.34 -0.18%
PFE Pfizer Inc 4.74% 35.72 -0.36%
ABT Abbott Laboratories 3.74% 87.45 -1.14%
BMY Bristol-Myers Squibb Company 3.65% 65.63 +0.71%
MDT Medtronic PLC 3.65% 113.28 -0.51%
ABBV AbbVie Inc 3.33% 94.96 +0.77%
TMO Thermo Fisher Scientific Inc 3.22% 334.94 -0.33%
AMGN Amgen Inc 3.15% 222.79 +0.29%
As of Feb. 20, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks to track the investment results of the Dow Jones U.S. Health Care Index composed of U.S. equities in the healthcare sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name iShares
Benchmark Index
DJ US Health Care TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Alan Mason 3.55 yrs
Amy Whitelaw 1.17 yrs
Greg Savage 11.84 yrs
Jennifer Hsui 7.17 yrs
Rachel Aguirre 1.17 yrs

Net Fund Flows

1M 43.00M
3M 35.32M
6M -41.51M
YTD 43.00M
1Y -437.44M
3Y -152.71M
5Y -432.00M
10Y -122.23M
As of Jan. 31, 2020

Risk Info

Beta (5Y) 0.9407
Max Drawdown (All) 43.13%
Historical Sharpe Ratio (10Y) 1.166
Historical Sortino (All) 0.5604
30-Day Rolling Volatility 13.19%
Daily Value at Risk (VaR) 1% (All) 3.18%
Monthly Value at Risk (VaR) 1% (All) 12.57%

Fundamentals

Dividend Yield TTM (2-21-20) 1.41%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 24.35
Weighted Average Price to Sales Ratio 2.042
Weighted Average Price to Book Ratio 4.231
Weighted Median ROE 21.54%
Weighted Median ROA 7.73%
Forecasted Dividend Yield 1.54%
Forecasted PE Ratio 16.16
Forecasted Price to Sales Ratio 1.825
Forecasted Price to Book Ratio 3.839
Number of Holdings 123
As of Feb. 20, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 9.76%
Forecasted Book Value Growth 4.40%
Forecasted Cash Flow Growth 10.41%
Forecasted Earnings Growth 18.88%
Forecasted Revenue Growth 10.34%
As of Feb. 20, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 6/12/2000
Termination Date
Last Annual Report Date 4/30/2019
Last Prospectus Date 8/30/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.